Kelly Mercier, PhD, joined the team as Chair of the DTRFCC in November 2020. She is a grant recipient of the DTRF for her work in metabolomics, the Principal Investigator of the DTRF Natural History Study and Patient Registry Principal Investigator, Diagnostic Regional Medical Lead (Lung Oncology) at Daiichi Sankyo, Inc, and an adjunct associate professor at Duke University.
Dr. Mercier specializes in designing, implementing, and prompting the adoption of novel therapies and diagnostic assays in oncology. She has received grants to understand the metabolic differences between desmoid tumors and normal adjacent tissue in the same patient with Dr. Ben Alman. Dr. Mercier is passionate about desmoid tumor research and is thrilled to be able to contribute her scientific knowledge to better understand and treat desmoid tumors.
